Melanoma
Latest News
SPF is only the start when recommending sunscreens
In a recent study, 43% of dermatologists who responded to a survey reported that they never, rarely, or only sometimes took a patient’s skin type...
Case Letter
Eruptive Keratoacanthomas After Nivolumab Treatment of Stage III Melanoma
Eruptive keratoacanthomas (KAs) are a rare buttransient adverse effect of programmed cell death protein 1 (PD-1) inhibitor therapy.
Latest News
Teledermatology follow-up after Mohs surgery gets a thumbs up from patients
“A big takeaway from our study is that streamlining this process is really essential for successful implementation,” Laura Rezac, MD, said.
Latest News
Mohs surgery workforce continues to increase
“If the attrition rate remains stable, even with changes in board certification and potential payor eligibility restrictions, the number of...
From the Journals
Number of cancer survivors with functional limitations doubled in 20 years
The 70% prevalence of functional limitation among survivors in 2018 is nearly twice that of the general population.
Original Research
Disparities in Melanoma Demographics, Tumor Stage, and Metastases in Hispanic and Latino Patients: A Retrospective Study
In this study, we evaluated recent data from the last decade to investigate if disparities in melanoma tumor stage at diagnosis and risk for...
Coding
Coding the “Spot Check”: Part 1
The updated outpatient evaluation and management (E/M) coding paradigm went into effect in January 2021, with level of visit being based on time...
Commentary
Gene Expression Profiling for Melanoma Prognosis: Going Beyond What We See With Our Eyes
Gene expression panels have now been approved by numerous third-party insurers to help predict future clinical evolution of biopsied melanomas....
Original Research
Artificial Intelligence vs Medical Providers in the Dermoscopic Diagnosis of Melanoma
This study sought to determine the performance of an artificial intelligence (AI) application in classifying lesions as benign or malignant to...
Conference Coverage
Guidelines for assessing cancer risk may need updating
Whole-exome sequencing reveals cancer risk mutations in patients that would not have qualified for testing based on current guidelines.
Conference Coverage
‘Exciting’ results for cancer vaccine plus pembro in melanoma
A new randomized study is the first to demonstrate improvement in recurrence-free survival in melanoma with an individualized neoantigen vaccine...